This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Talon, J.
Right arrow Articles by García-Sastre, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Talon, J.
Right arrow Articles by García-Sastre, A.

 Previous Article  |  Next Article 

Journal of Virology, September 2000, p. 7989-7996, Vol. 74, No. 17
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein

Julie Talon,1 Curt M. Horvath,2 Rosalind Polley,3 Christopher F. Basler,1 Thomas Muster,4 Peter Palese,1,* and Adolfo García-Sastre1

Department of Microbiology1 and Immunobiology Center,2 Mount Sinai School of Medicine, New York, New York 10029; Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath, England3; and Department of Dermatology, University of Vienna Medical School, 1090 Vienna, Austria4

Received 1 February 2000/Accepted 8 June 2000


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

We present a novel mechanism by which viruses may inhibit the alpha/beta interferon (IFN-alpha /beta ) cascade. The double-stranded RNA (dsRNA) binding protein NS1 of influenza virus is shown to prevent the potent antiviral interferon response by inhibiting the activation of interferon regulatory factor 3 (IRF-3), a key regulator of IFN-alpha /beta gene expression. IRF-3 activation and, as a consequence, IFN-beta mRNA induction are inhibited in wild-type (PR8) influenza virus-infected cells but not in cells infected with an isogenic virus lacking the NS1 gene (delNS1 virus). Furthermore, NS1 is shown to be a general inhibitor of the interferon signaling pathway. Inhibition of IRF-3 activation can be achieved by the expression of wild-type NS1 in trans, not only in delNS1 virus-infected cells but also in cells infected with a heterologous RNA virus (Newcastle disease virus). We propose that inhibition of IRF-3 activation by a dsRNA binding protein significantly contributes to the virulence of influenza A viruses and possibly to that of other viruses.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Cells have the potential to respond quickly to virus infection by activation of the interferon (IFN) pathway. This rapid response is possible because of constitutively expressed transcriptional regulators, such as IFN regulatory factor 3 (IRF-3). The importance of IRF-3 in the initiation of the innate antiviral response has only recently been demonstrated (30, 31, 38, 41). IRF-3 acts as a sentinel of sorts: upon virus infection or exposure to double-stranded RNA (dsRNA), IRF-3 is rapidly activated by phosphorylation on several C-terminal serine and threonine residues (2, 22). Phosphorylation of IRF-3 results in its nuclear accumulation, where it assembles with other transcription factors and contributes to the induction of the transcription of specific defense genes, including beta interferon (IFN-beta ) (19, 30, 37). This in turn initiates the IFN cascade to induce an antiviral state in the cell.

Several viruses encode factors that target specific mediators of the antiviral state (reviewed in reference 34). Among the best-characterized viral targets are protein kinase R (PKR) and (2'-5') oligoadenylate synthetase (12, 18). The IRF family has also recently been shown to be a strategic target for viruses such as human herpesvirus 8, which encodes viral IRF homologues (3, 4, 28). The E6 protein of human papillomavirus is known to bind directly to IRF-3, inhibiting the transcriptional activation of the IFN-beta gene (29). The ability of viruses to inhibit the host IFN system is most likely a major determinant of their pathogenic properties.

We have demonstrated that an influenza A virus lacking the NS1 protein (delNS1 virus), but not wild-type influenza A virus, strongly induces the production of IFN in vivo and the stimulation of an IFN-regulated gene (13; M. Salvatore and A. Garcia-Sastre, unpublished data). Results from the present study indicate that differential activation of IRF-3 correlates with differences in IFN induction between these two influenza viruses. The NS1 protein of influenza virus has been associated with multiple activities, including the binding of dsRNA (reviewed in reference 20). We hypothesize that the influenza virus NS1 protein, by binding to the dsRNA generated during influenza virus infection, prevents the activation of this key mediator of the innate cellular immune response. The inhibition of IRF-3 activation by an influenza virus-encoded dsRNA binding protein represents a novel mechanism by which IFN synthesis can be inhibited. This mechanism may be relevant to the pathogenesis of other viruses.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Viruses and cells. DelNS1 virus was generated by ribonucleoprotein transfection of an altered viral influenza NS gene, using the temperature-sensitive helper virus 25A-1 as described previously (13). Influenza A viruses, Sendai virus, and Newcastle disease virus (NDV) were grown in embryonated chicken eggs (SPAFAS, Inc.) at 37°C for 48 h. Seven-day-old embryonated eggs were used to grow delNS1 virus stock, since delNS1 virus is unable to counteract the IFN response present in older eggs (25, 32). Ten-day-old embryonated eggs were used to grow wild-type PR8 virus, Sendai virus, or NDV. Approximately 100 PFU of virus was injected into each egg. Plaque assay of influenza A virus or NDV stocks was performed on MDCK cells in the presence of 2 µg of trypsin (Difco Laboratories)/ml at 37°C.

HEC-1b cells (ATCC) are endometrial carcinoma cells of human epithelial origin. These cells have been used by several groups for IRF-3 analyses since they are reportedly nonresponsive to interferon (5, 11). U3A cells have homozygous mutations in the STAT1 gene, a signal transducer required for alpha/beta IFN (IFN-alpha /beta ) signaling (24). Therefore, any effect on the IFN response pathway in either of these cell lines should be independent of IFN signaling. 293T cells are human epithelial cells which are known to express simian virus 40 large T antigen.

Expression plasmids. pCAGGS-NS1(SAM) and pCAGGS-NS1-R38AK41A(SAM) contain the open reading frame of NS1 from wild-type influenza A (PR8) virus in an expression vector containing a chicken beta -actin promotor (pCAGGS) (26). The Stratagene Quikchange site-directed mutagenesis kit was used to mutate the splice acceptor in the plasmid pT3NS using the oligonucleotides NS3ss (5'-ATTGCCTTCTCTTCCCGGACATACTGCTGAG-3') and NS2ss2 (5'-CTCAGCAGTATGTCCGGGAAGAGAAGGCAAT-3') as instructed by the manufacturer. The splice acceptor mutation was confirmed by sequencing. NS1 "SAM" was then amplified by PCR using the oligonucleotides NS1EcoRI5' (5'-GCGCGAATTCAATAATGGATCCAAACACTG-3') and NS1XhoI3' (5'-GCGCCTCGAGTCAAACTTCTGACCTAATT-3') and cloned between the EcoRI and XhoI sites of pCAGGS, creating pCAGGS-NS1(SAM). pCAGGS-NS1-R38AK41A(SAM) was constructed by PCR amplification of two fragments from pCAGGS-NS1(SAM) and encodes an NS1 protein with mutations at amino acid positions 38 (Rright-arrowA) and 41 (Kright-arrowA) and which contains a silent NheI site. PCRs were performed using primers NS1EcoRI5' and R38AK41A.b (5'-GATCGGCTTCGCGCAGATCAGGCTAGCCTAAGAGGAAGA-3') and R38AK41A.t (5'-TCTTCCTCTTAGGCTAGCCTGATCTGCGCGAAGCCGATC-3') and NS1XhoI3'. The PCR products were digested with EcoRI and NheI and with NheI and XhoI, respectively, and cloned into pCAGGS between the EcoRI and XhoI sites. Mutations were confirmed by sequencing.

pGFP-mIRF-3 expresses green fluorescent protein (GFP) fused to mouse IRF-3 (71% identical to human IRF-3) and was a gift of Tak Mak (University of Toronto, Toronto, Ontario, Canada). GFP-mIRF-3 was found to be concentrated in the nucleus in response to delNS1 virus or NDV infection in a variety of cell lines, including U3A, HEC-1b, and CV1 (data not shown).

pCAGGS-hIRF3 expresses the human IRF-3 open reading frame, which was amplified from HeLa cell mRNA by reverse transcription using an oligodeoxyribosylthymine primer, followed by PCR using the primers IRF-3/5'EcoRI (5'-CCGGAATTCATAATGGGAACCCCAAAG-3') and IRF-3/3'XhoI (5'-CCGCTCGAGTCAGCTCTCCCCAGGGCC-3'). The IRF-3 PCR product was cloned into the pCAGGS vector between the EcoRI and XhoI sites.

Transfection and infection. Transfections were performed using Lipofectamine 2000 (Gibco) as instructed by the manufacturer. Where indicated, an empty vector (pCAGGS) was added to maintain a constant amount of 0.5 µg of DNA for each transfection per 24-well coverslip. HEC-1b and U3A transfections were performed in duplicate and incubated at 37°C for 24 h before the addition of virus. Transfected cells were infected with a multiplicity of infection (MOI) of 1 with delNS1 or PR8 virus and with an MOI of 2 for NDV. For the Western blot of transfected IRF-3 expression, 293T cells were transfected in suspension and then plated onto 35-mm dishes. Twenty-four hours later, cells were infected with an MOI of approximately 3 for delNS1 virus or approximately 10 for PR8 virus or Sendai virus. Infections were performed in phosphate-buffered saline (PBS) for 1 h at 37°C. After 1 h, medium (Dulbecco modified Eagle medium and 10% fetal calf serum) was added (t = 0) and the mixture was incubated for the indicated time.

Fluorescence. Cells were fixed and permeabilized for 20 min at room temperature with 2.5% formaldehyde-0.5% Triton X-100. Fixed cells were washed extensively with PBS and, where indicated, incubated with a monoclonal antibody to hIRF-3 (SL-12, kindly provided by Peter Howley) (dilution, 1:500) and a rabbit polyclonal antibody directed against the influenza virus NS1 protein (27) (dilution, 1:2,000) for 12 h. Washed cells were incubated with secondary antibodies directed against mouse (dilution, 1:750) or rabbit (dilution, 1:1,500) immunoglobulin G (IgG) (Texas Red or fluorescein isothiocyanate, respectively). All antibodies were diluted in PBS with 3% bovine serum albumin. Cells were affixed to slides, using mounting medium containing an antifade reagent (Molecular Probes). Approximately 100 to 500 cells for each experimental condition were counted using an Olympus IX-70 fluorescence microscope fitted with a Sony Catseye digital camera. Slide labels were covered during counting to minimize bias. Digital images were processed using Photoshop 4.01 software on a Macintosh Power PC.

Western analysis. Approximately 106 infected 293T cells were pelleted and lysed in 100 µl of sodium dodecyl sulfate (SDS) buffer (0.5% SDS, 0.05 M Tris 7.5, 1 mM dithiothreitol). One percent of the cell extract was resolved by SDS-10% polyacrylamide gel electrophoresis (PAGE), and the gel was transferred to a nitrocellulose membrane. Transfected IRF-3 was detected by chemiluminescence using a monoclonal antibody against IRF-3 (SL-12; dilution, 1:1,000 in 5% milk), and an anti-mouse IgG peroxidase-labeled antibody (Amersham; dilution, 1:10,000 in 5% milk).

RT-PCR of IFN-beta mRNA. Total RNA was prepared from confluent 100-mm dishes of HEC-1b cells or HEC-1b cells infected with NDV, influenza A/PR8 virus, or delNS1 virus at an MOI of 1 for 14 h using Trizol reagent (Gibco). The RNA was digested with DNase 1 and subjected to reverse transcription (RT)-PCR analysis essentially as previously described (17).

RNA was reverse transcribed with Moloney murine leukemia virus reverse transcriptase using random hexamer primers. A mock reaction was carried out with no reverse transcriptase added (-RT). One tenth of the resulting cDNA was used as a template for 25 cycles of PCR in the presence of [32P]dATP using specific primers for IFN-beta or glyceraldehyde-3-phosphate-dehydrogenase (GAPDH). As a control for genomic DNA contamination, PCR was carried out with GAPDH primers using the mock (-RT) reactions as a template. Following polyacrylamide gel electrophoresis (PAGE), products were detected by autoradiography. The following primer sequences were used: GAPDH a, 5'-GTGAAGGTCGGAGTCAAC-3'; GAPDH b, 5'-TGGAATTTGCCATGGGTG-3'; IFN-beta a, 5'-CACGACAGCTCTTTCCATGA-3'; and IFN-beta b, 5'-AGCCAGTGCTCGATGAATCT-3'.


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Inhibition of hIRF3 activation by wild-type influenza virus but not by a virus lacking NS1. Several groups have demonstrated that a hallmark of IRF-3 activation in virus-infected cells is its nuclear accumulation (22, 38). We examined whether infection by wild-type influenza A PR/8/34 virus (PR8) or by an isogenic virus lacking the NS1 open reading frame (delNS1 virus) resulted in the nuclear accumulation of IRF-3. To address this question, HEC-1b cells were infected with either PR8 or delNS1 virus at an MOI of 1. As shown in Fig. 1A, delNS1 virus infection resulted in the nuclear accumulation of hIRF-3. At 8 h postinfection, more than 80% of delNS1 virus-infected cells showed a strong nuclear hIRF-3 signal (Fig. 1B). This nuclear IRF-3 immunofluorescence signal was clearly distinguishable from the staining pattern of IRF-3 in mock-infected cells, which showed a diffuse IRF-3 signal spread throughout the nucleus and the cytoplasm. Very few cells (<10%) with bright nuclear IRF-3 could be found among cells infected with wild-type PR8 influenza virus at 8 h postinfection. The IRF-3 staining pattern of the majority (>90%) of the cells infected with PR8 virus was indistinguishable from that of mock-infected cells (Fig. 1A and B). A time course of infection with delNS1 virus showed a gradual increase in the percentage of cells showing nuclear hIRF-3 over time, with a rapid increase between 4 and 8 h postinfection (Fig. 1B).




View larger version (74K):
[in this window]
[in a new window]
  		FIG. 1.   Nuclear accumulation of hIRF-3 in delNS1 virus-infected cells. (A) Coverslips coated with Hec-1b cells were mock infected or infected with delNS1 or wild-type influenza A virus (PR8) at an MOI of 1. At 8 h postinfection, fixed cells were stained with a monoclonal antibody directed against human IRF-3 (SL-12). (B) HEC-1b cells were infected with delNS1 or PR8 virus for 2, 4, or 8 h. At the given time points, fixed cells were stained with SL-12 and scored according to subcellular distribution of hIRF-3. (C) 293T cells were transfected with pCAGGS-hIRF-3 and infected 24 h later with either Sendai, PR8, or delNS1 virus or were mock infected. At 16 h postinfection, total cell lysates were probed with alpha -IRF-3 as indicated in Materials and Methods.

Furthermore, we wanted to confirm that the differences seen in IRF-3 localization in PR8 virus-infected cells versus delNS1 virus-infected cells were indeed due to the phosphorylation state of IRF-3. Others have shown that the phosphorylation of IRF-3 results in a more slowly migrating species when resolved by SDS-PAGE (22, 38). We therefore examined the migration patterns of IRF-3 in response to either PR8 or delNS1 virus infection. As shown by Western analysis in Fig. 1C, infection with either Sendai virus or delNS1 virus results in an increase in the amount of a more slowly migrating (activated) species of IRF-3, whereas levels of this form in PR8 virus-infected cells appear to be roughly equivalent to those found in mock-infected cells.

Inhibition of hIRF-3 activation by transient expression of wild-type NS1 but not by expression of a dsRNA binding mutant of NS1. To examine whether a correlation exists between expression of wild-type NS1 and inhibition of hIRF-3 activation during virus infection, a plasmid encoding wild-type NS1 was transfected into HEC-1b cells. Transfected cells were then infected the next day with either delNS1 or PR8 virus (MOI = 1) for 8 h. Cells were scored according to NS1 expression and IRF-3 distribution. As shown in Fig. 2A, the majority of cells (between 70 and 80%) which did not show detectable levels of NS1 expression [NS1 (-)] showed nuclear accumulation of endogenous hIRF-3 in response to delNS1 infection. Transfection with 0.02 to 0.5 µg of pCAGGS-NS1(SAM), however, had a discernible effect on the nuclear accumulation of IRF-3 in response to delNS1 virus infection. Among cells expressing NS1 [NS1 (+)], a marked reduction in the percentage of cells showing activated (strong nuclear) IRF-3 compared to NS1 (-) cells was evident (Fig. 2A and B). Roughly 15 to 40% of NS1 (+) cells showed a nuclear accumulation of hIRF-3. The fraction of NS1 (+) cells with nuclear accumulation of IRF-3 did not appear to vary substantially with increasing amounts of pCAGGS-NS1(SAM) transfected per coverslip. However, a modest reduction in the fraction of NS1 (+) cells with activated hIRF-3 was observed between coverslips transfected with 0.02 µg and those transfected with 0.1 µg of the expression plasmid (from approximately 40 to 20%, respectively). We also tested whether the dsRNA binding activity of NS1 is required to inhibit IRF-3 activation. To assess this, a plasmid encoding an NS1 mutant [NS1-R38AK41A-(SAM)] was transfected into cells. The NS1-R38AK41A-(SAM) open reading frame encodes a protein with two mutations (R38 to A and K41 to A) which have been shown by others to abolish or severely diminish, respectively, the ability of NS1 to bind to RNA (36). As shown in Fig. 2A and C, expression of the mutant NS1 protein had no effect on the nuclear accumulation of IRF-3. Approximately 70% of both NS1-R38AK41A (+) and NS1-R38AK41A (-) cells showed nuclear accumulation of IRF-3.





View larger version (90K):
[in this window]
[in a new window]
  		FIG. 2.   Effect on delNS1 virus-induced nuclear accumulation of hIRF-3 in HEC-1b cells by transient transfection of influenza virus NS1 proteins. (A) Coverslips coated with HEC-1b cells were transfected with a plasmid expressing the wild-type influenza virus NS1 protein [pCAGGS-NS1(SAM)] or an NS1 RNA binding mutant [pCAGGS-NS1-R38AK41A(SAM)] (mut) or with an empty vector [pCAGGS]. Both NS1 open reading frames contain a splice acceptor mutation (SAM) to ensure that spliced NEP mRNA is not produced. (The NEP is a second protein normally produced by alternative splicing from the influenza A virus NS gene.) Except with PR8-infected cells and with the no-DNA control, the amount of DNA in all transfected cells was standardized to 0.5 µg per coverslip using pCAGGS. Coverslips were transfected with either 0, 0.02, 0.1, or 0.5 µg of pCAGGS-NS1(SAM) or with 0.5 µg of pCAGGS-NS1-R38AK41A(SAM) and infected with delNS1 virus at an MOI of 1 for 8 h. Fixed cells were stained with antibodies directed against the NS1 protein and endogenous hIRF-3. Cells were scored according to NS1 expression and hIRF-3 distribution. Bars represent the mean cell number from between 5 and 13 random fields per experimental condition. Asterisks indicate that there was no NS1 expression. (B) HEC-1b cells were transfected with 0.1 µg of pCAGGS-NS1(SAM) and infected with delNS1 virus as indicated for panel A. Cells were stained with a rabbit polyclonal antibody against NS1 and a mouse monoclonal antibody against hIRF-3. Anti-rabbit IgG (fluorescein isothiocyanate) and anti-mouse IgG (Texas Red) were used as secondary antibodies. In the top panel, arrows indicate two cells expressing the NS1 protein (green). The surrounding cells do not express detectable levels of NS1. In the bottom panel, arrows indicate the same two cells, demonstrating a lack of nuclear accumulation of hIRF-3. Surrounding cells which did not express the NS1 protein show a bright, nuclear accumulation of endogenous IRF-3. (C) Cells were transfected with 0.1 µg of pCAGGS-NS1-R38AK41A(SAM) and infected with delNS1 for 8 h as described for panel A. Fixed cells were stained as described above. In the top panel, arrows indicate cells which show expression of the NS1-R38AK41A protein (green). The immunofluorescence staining pattern of NS1-R38AK41A was essentially the same as that of wild-type NS1, with bright nuclear staining. In addition to the nuclear signal, a diffuse cytoplasmic signal could also be detected in some cells expressing NS1-R38AK41A. The bottom panel shows NS1-R38AK41A-expressing cells with bright, nuclear accumulation of hIRF-3 (red). (D) HEC-1b cells were infected for 8 h with PR8 virus at an MOI of 1. Fixed cells were stained as described for panel B. The top panel shows virally expressed NS1 protein (green). The arrows indicate a cell which, when examined for IRF-3 localization (bottom panel, red), showed nuclear accumulation of IRF-3. Most cells are infected and are expressing viral NS1. The majority of PR8-infected cells do not, however, show nuclear accumulation of IRF-3. As indicated by the arrow (bottom panel), only one out of six infected cells in this field showed nuclear accumulation of IRF-3.

PR8 virus-infected cells were also examined for NS1 expression and IRF-3 localization. A very small percentage of PR8 virus-infected cells demonstrated a nuclear accumulation of IRF-3, and this fraction did not appear to differ significantly between NS1 (+) and NS1 (-) cells. The NS1(-) cells in the PR8-infected coverslips are most likely uninfected cells, which would explain their low level of IRF-3 activation (<5%). Expression of either wild-type or mutant (R38AK41A) NS1 from an expression plasmid did not appear to effect the percentage of PR8-infected cells showing nuclear accumulation of IRF-3 (data not shown).

Influenza virus NS1-mediated inhibition of IRF-3 activation induced by a heterologous virus. NDV is a known activator of IFN-alpha /beta in several cell types and has been demonstrated to be a potent inducer of IRF-3 activation (41). We asked whether the influenza virus NS1 protein could prevent or delay the activation of IRF-3 by NDV or whether this inhibitory effect of NS1 was specific to influenza virus infection. For this experiment we used a plasmid expressing GFP fused to mouse IRF-3 (pGFP-mIRF-3) and human U3A cells, which have a homozygous disruption in the STAT1 gene. U3A cells have been shown to be nonresponsive to IFN (24). When transfected with pGFP-mIRF-3, U3A cells show a bright nuclear accumulation of GFP-mIRF-3 in response to delNS1 infection, confirming results obtained with endogenous hIRF-3 (data not shown). U3A cells were transfected with pGFP-mIRF3 and cotransfected with either pCAGGSNS1(SAM) or an empty vector (pCAGGS). At 24 h posttransfection, cells were infected with NDV as indicated. At 7 h postinfection, cells transfected with an empty pCAGGS vector showed distinct nuclear localization of GFP-mIRF-3 in more than 90% of the fields examined (Fig. 3, top). However, several fields of cells in coverslips which had received the NS1 expression plasmid showed striking cytoplasmic GFP-mIRF3 localization (Fig. 3, bottom). The apparent increase in the intensity of GFP expression in the NS1-transfected cells over that in control plasmid-transfected cells is likely due to the ability of NS1 to enhance translation (9, 10). Cotransfection of an NS1 expression plasmid resulted in a marked reduction (from 94.8 to 38.2%) in the mean percentage of NDV-infected cell fields showing nuclear GFP-mIRF-3 accumulation.


View larger version (81K):
[in this window]
[in a new window]
  		FIG. 3.   Inhibition of NDV-induced nuclear accumulation of GFP-mIRF3 in U3A cells by transient transfection of the influenza virus NS1 protein. Coverslips coated with U3A fibroblasts were transfected with pGFP-mIRF3 plus pCAGGS-NS1(SAM) or an empty vector (pCAGGS). At 24 h posttransfection, cells were infected with NDV at an MOI of 2 for 7 h. Washed cells were then fixed and examined for GFP-mIRF-3 distribution. Fluorescence of GFP-mIRF-3 in NDV infected cells ± NS1 is shown.

Differential induction of IFN-beta mRNA in influenza A PR8 virus-infected cells versus that in delNS1 virus-infected cells. The correlation between the nuclear accumulation of IRF-3 and its activation as a positive regulator of the transcription of a subset of IFN-related genes, including IFN-beta , is well documented (22, 30, 38, 41). Given the pronounced inhibition of IRF-3 nuclear accumulation in PR8-infected cells compared to that in cells infected with delNS1 virus, we examined whether a difference in the induction of IFN-beta mRNA by these two viruses could be detected. Confluent 100-mm dishes of HEC-1b cells were infected at an MOI of 1 for 14 h as indicated. RT-PCR of infected cell extracts using primers specific for human IFN-beta mRNA resulted in a prominent band in NDV- and delNS1-infected cells. RT-PCR of cell extracts from cells infected with the same MOI of wild-type PR8 influenza virus, however, did not produce a detectable band corresponding to IFN-beta mRNA. Amplification of a housekeeping gene, GAPDH, was consistent for all viruses tested as well as for mock-infected cells.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Activation of IRF-3 in delNS1-infected cells versus that in PR8 virus-infected cells. Two influenza A viruses, which differ genetically by the presence of the NS1 open reading frame, were compared for their ability to induce the activation of IRF-3. Infection with delNS1 virus dramatically induced the activation and nuclear accumulation of IRF-3 (Fig. 1). Infection with PR8 virus, on the other hand, resulted in IRF-3 nuclear accumulation in a very limited number of cells. dsRNA generated during virus infection is thought to be one of the key signals in the induction of the IFN cascade, initiating the response by activation of IRF-3. The NS1 protein is produced early in wild-type influenza virus infection (33) and is one of the most abundant proteins in the infected cell. In the context of viral infection, NS1 can be found in both the nucleus and the cytoplasm (21, 39). One of the pleiotropic activities associated with NS1 is the ability to bind to dsRNA in vitro (14, 16, 23). We therefore hypothesize that the NS1 protein present in PR8-infected cells is directly responsible for the differences seen in IRF-3 activation (see Fig. 5).

Induction of the IFN-beta promotor by dsRNA or viral infection appears to be mediated by the coordinated activation of at least three transcription factors: IRF-3, NF-kappa B, and ATF/c-Jun (19, 30, 37, 38). The role of the dsRNA protein kinase PKR in the induction of the IFN cascade is not well understood. We and others have demonstrated that the influenza virus NS1 protein is able to inhibit the activation of this cellular kinase (1, 15, 23, 35). While it is becoming clear that PKR plays a critical role in NF-kappa B activation by dsRNA or viral infection in cell culture (6), there is no evidence suggesting a role of PKR in IRF-3 activation. Moreover, IFN-alpha /beta mRNA induction in response to virus infection has been reported to be unimpaired in mice lacking functional PKR (40). Nevertheless, if PKR is directly involved in IRF-3 activation, NS1-mediated inhibition of PKR may partially explain the low levels of IRF-3 phosphorylation and IFN-beta mRNA induction seen in PR8 virus-infected cells. The specific role of PKR in IRF-3 activation, therefore, awaits further clarification. In addition, the effect of NS1 expression on the activation of other dsRNA-responsive transcription factors, such as NF-kappa B and ATF/c-Jun, is currently under investigation.

NS1 is a general inhibitor of IRF-3 activation which requires an intact dsRNA binding domain. We next asked whether the exogenous expression of the NS1 protein from a plasmid would have an effect on IRF-3 localization in delNS1 virus-infected cells. Transfected cells were infected with delNS1 virus for 8 h and examined for NS1 expression and for the subcellular distribution of IRF-3 (Fig. 2). Even when expressed in trans, NS1 clearly had an effect on IRF-3 localization in delNS1-infected cells. Furthermore, this effect could be observed in a different system using a heterologous virus (NDV) and a different readout (pGFP-mIRF-3 expression) (Fig. 3). Since the influenza virus NS1 protein is able to bind both to model influenza virus RNA and nonspecifically to dsRNA in vitro (14, 16, 23), it is conceivable that the influenza virus NS1 protein may act in a general sense to bind and sequester any viral and/or double-stranded forms of RNA which could potentially activate IRF-3. This hypothesis is strengthened by the fact that cells expressing a mutant NS1 which lacks a functional RNA binding domain (R38AK41A-NS1) (36) show the same level of IRF-3 activation as control cells (Fig. 2).

IFN-beta mRNA induction. Activation of IRF-3 results in its nuclear accumulation, where it assembles with CREB-binding protein (CBP/p300) as part of the transcriptional complex DRAF1 (dsRNA-activated factor 1) (38). dsRNA-activated factor 1 binds to IFN-beta - and IFN-alpha 4 promoters, contributing to their transcriptional activation (7, 8). We therefore examined whether the differences we saw in IRF-3 activation between delNS1 virus- and PR8 virus-infected cells correlated with differences in IFN-beta mRNA induction. We found that delNS1 virus infection induced the transcription of detectable levels of IFN-beta mRNA, whereas PR8 virus infection did not (Fig. 4). Infection with PR8 virus, which encodes the NS1 protein, is therefore much less likely to induce the downstream antiviral effects of IFN-alpha /beta than the isogenic virus lacking this IFN antagonist. Which specific antiviral pathways are affected, and to what degree, await further analysis.


View larger version (22K):
[in this window]
[in a new window]
  		FIG. 4.   Differential induction of IFN-beta mRNA in response to either PR8 or delNS1 virus infection. Confluent 100-mm dishes of HEC-1b cells were infected with either NDV, PR8 virus, or delNS1 virus at an MOI of 1 for 14 h. One dish of mock (PBS)-infected cells was included as a negative control (-). At 14 h postinfection, cells were washed twice with cold PBS, and total RNA was subjected to RT-PCR analysis using specific primers for IFN-beta or GAPDH. As a control for genomic DNA contamination, PCR was carried out with GAPDH primers using the mock (-RT) reactions as a template. Following PAGE, products were detected by autoradiography.

The ability of a virus to inhibit the expression of defense genes such as IFN-beta is likely to be inextricably linked to its pathogenicity. This model is exemplified by the influenza virus system. We show that the presence of the NS1 protein in wild-type PR8 virus-infected cells is associated with an inhibition in the activation of IRF-3 and of the subsequent transcription of IFN-beta mRNA (Fig. 5B). Combined with our previous results showing the extreme differences in pathogenicity between the PR8 and delNS1 viruses (13), we propose that the ability of the NS1 protein to inhibit the activation of IRF-3 is an important virulence factor for influenza virus. It should be noted that the NS1 of PR8 virus could not completely prevent the activation of IRF-3 in infected cells. We therefore propose that variability within the NS1 sequence among different strains of influenza virus may be responsible for differences in ability to inhibit this arm of the immune system. These differences may play a role in virus pathogenicity.


View larger version (79K):
[in this window]
[in a new window]
  		FIG. 5.   Model for the mechanism of inhibition of IFN-alpha /beta induction by the influenza virus NS1 protein. (A) In the absence of the NS1 protein, dsRNA generated during the course of virus infection promotes the phosphorylation and nuclear accumulation of IRF-3 by a mechanism which has not yet been precisely defined. Once inside the nucleus, IRF-3 associates with other transcription factors and initiates the induction of the antiviral state by upregulating the transcription of cellular defense genes, including IFN-beta . (B) In the presence of NS1, dsRNA generated during viral infection is sequestered (in the nucleus and/or in the cytoplasm) and is unable to induce the nuclear accumulation of IRF-3. The transcription of IFN-beta mRNA is prevented, and the virus is able to avert the antiviral state induced by the IFN cascade.

We also propose that other viral dsRNA binding proteins, such as the E3L protein of poxviruses (42), may have an analogous mechanism for preventing IFN-alpha /beta synthesis. Finally, the design of compounds to specifically target the inhibitory activity on the IFN system could represent an alternative for the generation of novel antiviral agents. In the case of influenza viruses, compounds would be selected for their ability to prevent NS1-mediated abrogation of IRF-3 activation.


    ACKNOWLEDGMENTS

We thank Peter Howley (Harvard University, Boston, Mass.) for kindly providing the SL-12 mouse monoclonal antibody directed against human IRF-3. We also thank Tak Mak (University of Toronto, Toronto, Ontario, Canada) for the pGFP-mIRF-3 expression plasmid.

This work was supported in part by grants to A.G.-S. and P.P. from the National Institutes of Health and by Austrian Science Fund Project 12548-MOB (T.M.). T.M. was supported by the Austrian Academy of Sciences. C.F.B. was supported by an NIH NRSA fellowship.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Microbiology, Mount Sinai School of Medicine, One Gustave Levy Pl., New York, NY 10029. Phone: (212) 241-7318. Fax: (212) 722-3634. E-mail: peter.palese{at}mssm.edu.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Bergman, M., A. Garcia-Sastre, E. Carnero, H. Pehamberger, K. Wolff, P. Palese, and T. Muster. 2000. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 74:6203-6206[Abstract/Free Full Text].
2. Braganca, J., and A. Civas. 1998. Type I interferon gene expression: differential expression of IFN-A genes induced by viruses and double-stranded RNA. Biochimie 80:673-687[Medline].
3. Burysek, L., W. S. Yeow, B. Lubyova, M. Kellum, S. L. Schafer, Y. Q. Huang, and P. M. Pitha. 1999. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J. Virol. 73:7334-7342[Abstract/Free Full Text].
4. Burysek, L., W. S. Yeow, and P. M. Pitha. 1999. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). J. Hum. Virol. 2:19-32[Medline].
5. Chen, H. Y., T. Sato, A. Fuse, T. Kuwata, and J. Content. 1981. Resistance to interferon of a human adenocarcinoma cell line, HEC-1, and its sensitivity to natural killer cell action. J. Gen. Virol. 52:177-181[Abstract/Free Full Text].
6. Chu, W. M., D. Ostertag, Z. W. Li, L. Chang, Y. Chen, Y. Hu, B. Williams, J. Perrault, and M. Karin. 1999. JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 11:721-731[CrossRef][Medline].
7. Daly, C., and N. C. Reich. 1995. Characterization of specific DNA-binding factors activated by double-stranded RNA as positive regulators of interferon alpha/beta-stimulated genes. J. Biol. Chem. 270:23739-23746[Abstract/Free Full Text].
8. Daly, C., and N. C. Reich. 1993. Double-stranded RNA activates novel factors that bind to the interferon-stimulated response element. Mol. Cell. Biol. 13:3756-3764[Abstract/Free Full Text].
9. de la Luna, S., P. Fortes, A. Beloso, and J. Ortin. 1995. Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J. Virol. 69:2427-2433[Abstract].
10. Enami, K., T. A. Sato, S. Nakada, and M. Enami. 1994. Influenza virus NS1 protein stimulates translation of the M1 protein. J. Virol. 68:1432-1437[Abstract/Free Full Text].
11. Fuse, A., H. Ashino-Fuse, and T. Kuwata. 1984. Binding of 125I-labeled human interferon to cell lines with low sensitivity to interferon. Gann 75:379-384[Medline].
12. Gale, M., Jr., and M. G. Katze. 1998. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78:29-46[CrossRef][Medline].
13. Garcia-Sastre, A., A. Egorov, D. Matassov, S. Brandt, D. E. Levy, J. E. Durbin, P. Palese, and T. Muster. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324-330[CrossRef][Medline].
14. Hatada, E., and R. Fukuda. 1992. Binding of influenza A virus NS1 protein to dsRNA in vitro. J. Gen. Virol. 73:3325-3329[Abstract/Free Full Text].
15. Hatada, E., S. Saito, and R. Fukuda. 1999. Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J. Virol. 73:2425-2433[Abstract/Free Full Text].
16. Hatada, E., S. Saito, N. Okishio, and R. Fukuda. 1997. Binding of the influenza virus NS1 protein to model genome RNAs. J. Gen. Virol. 78:1059-1063[Abstract].
17. Horvath, C. M., G. R. Stark, I. M. Kerr, and J. E. Darnell, Jr. 1996. Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex. Mol. Cell. Biol. 16:6957-6964[Abstract].
18. Jacobs, B. L., and J. O. Langland. 1996. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219:339-349[CrossRef][Medline].
19. Juang, Y., W. Lowther, M. Kellum, W. C. Au, R. Lin, J. Hiscott, and P. M. Pitha. 1998. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc. Natl. Acad. Sci. USA 95:9837-9842[Abstract/Free Full Text].
20. Krug, R. M. 1998. Unique functions of the NS1 protein, p. 82-92. In K. G. Nicholson, R. G. Webster, and A. J. Hay (ed.), Textbook of influenza. Blackwell Science Ltd., Oxford, England.
21. Li, Y., Y. Yamakita, and R. M. Krug. 1998. Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein. Proc. Natl. Acad. Sci. USA 95:4864-4869[Abstract/Free Full Text].
22. Lin, R., C. Heylbroeck, P. M. Pitha, and J. Hiscott. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18:2986-2996[Abstract/Free Full Text].
23. Lu, Y., M. Wambach, M. G. Katze, and R. M. Krug. 1995. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the eIF-2 translation initiation factor. Virology 214:222-228[CrossRef][Medline].
24. McKendry, R., J. John, D. Flavell, M. Muller, I. M. Kerr, and G. R. Stark. 1991. High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. Proc. Natl. Acad. Sci. USA 88:11455-11459[Abstract/Free Full Text].
25. Morahan, P. S., and S. E. Grossberg. 1970. Age-related cellular resistance of the chicken embryo to viral infections. I. Interferon and natural resistance to myxoviruses and vesicular stomatitis virus. J. Infect. Dis. 121:615-623[Medline].
26. Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199[CrossRef][Medline].
27. Norton, G. P., T. Tanaka, K. Tobita, S. Nakada, D. A. Buonagurio, D. Greenspan, M. Krystal, and P. Palese. 1987. Infectious influenza A and B virus variants with long carboxyl terminal deletions in the NS1 polypeptides. Virology 156:204-213[CrossRef][Medline].
28. Pitha, P. M., W. C. Au, W. Lowther, Y. T. Juang, S. L. Schafer, L. Burysek, J. Hiscott, and P. A. Moore. 1998. Role of the interferon regulatory factors (IRFs) in virus-mediated signaling and regulation of cell growth. Biochimie 80:651-658[Medline].
29. Ronco, L. V., A. Y. Karpova, M. Vidal, and P. M. Howley. 1998. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12:2061-2072[Abstract/Free Full Text].
30. Sato, M., N. Tanaka, N. Hata, E. Oda, and T. Taniguchi. 1998. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett. 425:112-116[CrossRef][Medline].
31. Schafer, S. L., R. Lin, P. A. Moore, J. Hiscott, and P. M. Pitha. 1998. Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem. 273:2714-2720[Abstract/Free Full Text].
32. Sekellick, M. J., W. J. Biggers, and P. I. Marcus. 1990. Development of the interferon system. I. In chicken cells development in ovo continues on time in vitro. In Vitro Cell. Dev. Biol. 26:997-1003[Medline].
33. Shapiro, G. I., T. Gurney, Jr., and R. M. Krug. 1987. Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs. J. Virol. 61:764-773[Abstract/Free Full Text].
34. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264[CrossRef][Medline].
35. Tan, S. L., and M. G. Katze. 1998. Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J. Interferon Cytokine Res. 18:757-766[Medline].
36. Wang, W., K. Riedel, P. Lynch, C. Y. Chien, G. T. Montelione, and R. M. Krug. 1999. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 5:195-205[Abstract].
37. Wathelet, M. G., C. H. Lin, B. S. Parekh, L. V. Ronco, P. M. Howley, and T. Maniatis. 1998. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1:507-518[CrossRef][Medline]. (Erratum, 3:813.)
38. Weaver, B. K., K. P. Kumar, and N. C. Reich. 1998. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18:1359-1368[Abstract/Free Full Text].
39. Wolff, T., R. E. O'Neill, and P. Palese. 1998. NS1-binding protein (NS1-BP): a novel human protein that interacts with the influenza A virus nonstructural NS1 protein is relocalized in the nuclei of infected cells. J. Virol. 72:7170-7180[Abstract/Free Full Text].
40. Yang, Y. L., L. F. Reis, J. Pavlovic, A. Aguzzi, R. Schafer, A. Kumar, B. R. Williams, M. Aguet, and C. Weissmann. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14:6095-6106[Medline].
41. Yoneyama, M., W. Suhara, Y. Fukuhara, M. Fukuda, E. Nishida, and T. Fujita. 1998. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17:1087-1095[CrossRef][Medline].
42. Yuwen, H., J. H. Cox, J. W. Yewdell, J. R. Bennink, and B. Moss. 1993. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology 195:732-744[CrossRef][Medline].

Journal of Virology, September 2000, p. 7989-7996, Vol. 74, No. 17
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Chambers, R., Takimoto, T. (2009). Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products. J. Gen. Virol. 90: 1906-1915 [Abstract] [Full Text]  
  • Haye, K., Burmakina, S., Moran, T., Garcia-Sastre, A., Fernandez-Sesma, A. (2009). The NS1 Protein of a Human Influenza Virus Inhibits Type I Interferon Production and the Induction of Antiviral Responses in Primary Human Dendritic and Respiratory Epithelial Cells. J. Virol. 83: 6849-6862 [Abstract] [Full Text]  
  • Xing, Z., Cardona, C. J., Adams, S., Yang, Z., Li, J., Perez, D., Woolcock, P. R. (2009). Differential regulation of antiviral and proinflammatory cytokines and suppression of Fas-mediated apoptosis by NS1 of H9N2 avian influenza virus in chicken macrophages. J. Gen. Virol. 90: 1109-1118 [Abstract] [Full Text]  
  • Kakugawa, S., Shimojima, M., Goto, H., Horimoto, T., Oshimori, N., Neumann, G., Yamamoto, T., Kawaoka, Y. (2009). Mitogen-Activated Protein Kinase-Activated Kinase RSK2 Plays a Role in Innate Immune Responses to Influenza Virus Infection. J. Virol. 83: 2510-2517 [Abstract] [Full Text]  
  • Zurney, J., Kobayashi, T., Holm, G. H., Dermody, T. S., Sherry, B. (2009). Reovirus {micro}2 Protein Inhibits Interferon Signaling through a Novel Mechanism Involving Nuclear Accumulation of Interferon Regulatory Factor 9. J. Virol. 83: 2178-2187 [Abstract] [Full Text]  
  • Basu, D., Walkiewicz, M. P., Frieman, M., Baric, R. S., Auble, D. T., Engel, D. A. (2009). Novel Influenza Virus NS1 Antagonists Block Replication and Restore Innate Immune Function. J. Virol. 83: 1881-1891 [Abstract] [Full Text]  
  • Wressnigg, N., Shurygina, A. P., Wolff, T., Redlberger-Fritz, M., Popow-Kraupp, T., Muster, T., Egorov, A., Kittel, C. (2009). Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice. J. Gen. Virol. 90: 366-374 [Abstract] [Full Text]  
  • Hui, K. P. Y., Lee, S. M. Y., Cheung, C.-y., Ng, I. H. Y., Poon, L. L. M., Guan, Y., Ip, N. Y. Y., Lau, A. S. Y., Peiris, J. S. M. (2009). Induction of Proinflammatory Cytokines in Primary Human Macrophages by Influenza A Virus (H5N1) Is Selectively Regulated by IFN Regulatory Factor 3 and p38 MAPK. J. Immunol. 182: 1088-1098 [Abstract] [Full Text]  
  • Hale, B. G., Randall, R. E., Ortin, J., Jackson, D. (2008). The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89: 2359-2376 [Abstract] [Full Text]  
  • Bartlett, E. J., Cruz, A.-M., Esker, J., Castano, A., Schomacker, H., Surman, S. R., Hennessey, M., Boonyaratanakornkit, J., Pickles, R. J., Collins, P. L., Murphy, B. R., Schmidt, A. C. (2008). Human Parainfluenza Virus Type 1 C Proteins Are Nonessential Proteins That Inhibit the Host Interferon and Apoptotic Responses and Are Required for Efficient Replication in Nonhuman Primates. J. Virol. 82: 8965-8977 [Abstract] [Full Text]  
  • Nakatsu, Y., Takeda, M., Ohno, S., Shirogane, Y., Iwasaki, M., Yanagi, Y. (2008). Measles Virus Circumvents the Host Interferon Response by Different Actions of the C and V Proteins. J. Virol. 82: 8296-8306 [Abstract] [Full Text]  
  • Mayuri, , Geders, T. W., Smith, J. L., Kuhn, R. J. (2008). Role for Conserved Residues of Sindbis Virus Nonstructural Protein 2 Methyltransferase-Like Domain in Regulation of Minus-Strand Synthesis and Development of Cytopathic Infection. J. Virol. 82: 7284-7297 [Abstract] [Full Text]  
  • Jackson, D., Hossain, Md. J., Hickman, D., Perez, D. R., Lamb, R. A. (2008). A new influenza virus virulence determinant: The NS1 protein four C-terminal residues modulate pathogenicity. Proc. Natl. Acad. Sci. USA 105: 4381-4386 [Abstract] [Full Text]  
  • Hartman, A. L., Bird, B. H., Towner, J. S., Antoniadou, Z.-A., Zaki, S. R., Nichol, S. T. (2008). Inhibition of IRF-3 Activation by VP35 Is Critical for the High Level of Virulence of Ebola Virus. J. Virol. 82: 2699-2704 [Abstract] [Full Text]  
  • Goncharova, E. A., Goncharov, D. A., Chisolm, A., Spaits, M. S., Lim, P. N., Cesarone, G., Khavin, I., Tliba, O., Amrani, Y., Panettieri, R. A. Jr., Krymskaya, V. P. (2008). Interferon {beta} Augments Tuberous Sclerosis Complex 2 (TSC2)-Dependent Inhibition of TSC2-Null ELT3 and Human Lymphangioleiomyomatosis-Derived Cell Proliferation. Mol. Pharmacol. 73: 778-788 [Abstract] [Full Text]  
  • Jiao, P., Tian, G., Li, Y., Deng, G., Jiang, Y., Liu, C., Liu, W., Bu, Z., Kawaoka, Y., Chen, H. (2008). A Single-Amino-Acid Substitution in the NS1 Protein Changes the Pathogenicity of H5N1 Avian Influenza Viruses in Mice. J. Virol. 82: 1146-1154 [Abstract] [Full Text]  
  • Hale, B. G., Batty, I. H., Downes, C. P., Randall, R. E. (2008). Binding of Influenza A Virus NS1 Protein to the Inter-SH2 Domain of p85 Suggests a Novel Mechanism for Phosphoinositide 3-Kinase Activation. J. Biol. Chem. 283: 1372-1380 [Abstract] [Full Text]  
  • Gainey, M. D., Dillon, P. J., Clark, K. M., Manuse, M. J., Parks, G. D. (2008). Paramyxovirus-Induced Shutoff of Host and Viral Protein Synthesis: Role of the P and V Proteins in Limiting PKR Activation. J. Virol. 82: 828-839 [Abstract] [Full Text]  
  • Randall, R. E., Goodbourn, S. (2008). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89: 1-47 [Abstract] [Full Text]  
  • Zhu, Q., Yang, H., Chen, W., Cao, W., Zhong, G., Jiao, P., Deng, G., Yu, K., Yang, C., Bu, Z., Kawaoka, Y., Chen, H. (2008). A Naturally Occurring Deletion in Its NS Gene Contributes to the Attenuation of an H5N1 Swine Influenza Virus in Chickens. J. Virol. 82: 220-228 [Abstract] [Full Text]  
  • Tasaka, M., Sakamoto, N., Itakura, Y., Nakagawa, M., Itsui, Y., Sekine-Osajima, Y., Nishimura-Sakurai, Y., Chen, C.-H., Yoneyama, M., Fujita, T., Wakita, T., Maekawa, S., Enomoto, N., Watanabe, M. (2007). Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response. J. Gen. Virol. 88: 3323-3333 [Abstract] [Full Text]  
  • Shin, Y.-K., Li, Y., Liu, Q., Anderson, D. H., Babiuk, L. A., Zhou, Y. (2007). SH3 Binding Motif 1 in Influenza A Virus NS1 Protein Is Essential for PI3K/Akt Signaling Pathway Activation. J. Virol. 81: 12730-12739 [Abstract] [Full Text]  
  • Zeng, H., Goldsmith, C., Thawatsupha, P., Chittaganpitch, M., Waicharoen, S., Zaki, S., Tumpey, T. M., Katz, J. M. (2007). Highly Pathogenic Avian Influenza H5N1 Viruses Elicit an Attenuated Type I Interferon Response in Polarized Human Bronchial Epithelial Cells. J. Virol. 81: 12439-12449 [Abstract] [Full Text]  
  • Baskin, C. R., Bielefeldt-Ohmann, H., Garcia-Sastre, A., Tumpey, T. M., Van Hoeven, N., Carter, V. S., Thomas, M. J., Proll, S., Solorzano, A., Billharz, R., Fornek, J. L., Thomas, S., Chen, C.-H., Clark, E. A., Murali-Krishna, K., Katze, M. G. (2007). Functional Genomic and Serological Analysis of the Protective Immune Response Resulting from Vaccination of Macaques with an NS1-Truncated Influenza Virus. J. Virol. 81: 11817-11827 [Abstract] [Full Text]  
  • Newby, C. M., Sabin, L., Pekosz, A. (2007). The RNA Binding Domain of Influenza A Virus NS1 Protein Affects Secretion of Tumor Necrosis Factor Alpha, Interleukin-6, and Interferon in Primary Murine Tracheal Epithelial Cells. J. Virol. 81: 9469-9480 [Abstract] [Full Text]  
  • Holzinger, D., Jorns, C., Stertz, S., Boisson-Dupuis, S., Thimme, R., Weidmann, M., Casanova, J.-L., Haller, O., Kochs, G. (2007). Induction of MxA Gene Expression by Influenza A Virus Requires Type I or Type III Interferon Signaling. J. Virol. 81: 7776-7785 [Abstract] [Full Text]  
  • Kochs, G., Garcia-Sastre, A., Martinez-Sobrido, L. (2007). Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein. J. Virol. 81: 7011-7021 [Abstract] [Full Text]  
  • Roth-Cross, J. K., Martinez-Sobrido, L., Scott, E. P., Garcia-Sastre, A., Weiss, S. R. (2007). Inhibition of the Alpha/Beta Interferon Response by Mouse Hepatitis Virus at Multiple Levels. J. Virol. 81: 7189-7199 [Abstract] [Full Text]  
  • Kochs, G., Koerner, I., Thiel, L., Kothlow, S., Kaspers, B., Ruggli, N., Summerfield, A., Pavlovic, J., Stech, J., Staeheli, P. (2007). Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J. Gen. Virol. 88: 1403-1409 [Abstract] [Full Text]  
  • Muller, S., Geffers, R., Gunther, S. (2007). Analysis of gene expression in Lassa virus-infected HuH-7 cells. J. Gen. Virol. 88: 1568-1575 [Abstract] [Full Text]  
  • Aguilar, P. V., Weaver, S. C., Basler, C. F. (2007). Capsid Protein of Eastern Equine Encephalitis Virus Inhibits Host Cell Gene Expression. J. Virol. 81: 3866-3876 [Abstract] [Full Text]  
  • Saira, K., Zhou, Y., Jones, C. (2007). The Infected Cell Protein 0 Encoded by Bovine Herpesvirus 1 (bICP0) Induces Degradation of Interferon Response Factor 3 and, Consequently, Inhibits Beta Interferon Promoter Activity. J. Virol. 81: 3077-3086 [Abstract] [Full Text]  
  • Goodman, A. G., Smith, J. A., Balachandran, S., Perwitasari, O., Proll, S. C., Thomas, M. J., Korth, M. J., Barber, G. N., Schiff, L. A., Katze, M. G. (2007). The Cellular Protein P58IPK Regulates Influenza Virus mRNA Translation and Replication through a PKR-Mediated Mechanism. J. Virol. 81: 2221-2230 [Abstract] [Full Text]  
  • Hayman, A., Comely, S., Lackenby, A., Hartgroves, L. C. S., Goodbourn, S., McCauley, J. W., Barclay, W. S. (2007). NS1 Proteins of Avian Influenza A Viruses Can Act as Antagonists of the Human Alpha/Beta Interferon Response. J. Virol. 81: 2318-2327 [Abstract] [Full Text]  
  • Guo, Z., Chen, L.-m., Zeng, H., Gomez, J. A., Plowden, J., Fujita, T., Katz, J. M., Donis, R. O., Sambhara, S. (2007). NS1 Protein of Influenza A Virus Inhibits the Function of Intracytoplasmic Pathogen Sensor, RIG-I. Am. J. Respir. Cell Mol. Bio. 36: 263-269 [Abstract] [Full Text]  
  • Koerner, I., Kochs, G., Kalinke, U., Weiss, S., Staeheli, P. (2007). Protective Role of Beta Interferon in Host Defense against Influenza A Virus. J. Virol. 81: 2025-2030 [Abstract] [Full Text]  
  • Satterly, N., Tsai, P.-L., van Deursen, J., Nussenzveig, D. R., Wang, Y., Faria, P. A., Levay, A., Levy, D. E., Fontoura, B. M. A. (2007). Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc. Natl. Acad. Sci. USA 104: 1853-1858 [Abstract] [Full Text]  
  • Graff, J. W., Ewen, J., Ettayebi, K., Hardy, M. E. (2007). Zinc-binding domain of rotavirus NSP1 is required for proteasome-dependent degradation of IRF3 and autoregulatory NSP1 stability. J. Gen. Virol. 88: 613-620 [Abstract] [Full Text]  
  • Ostertag, D., Hoblitzell-Ostertag, T. M., Perrault, J. (2007). Overproduction of Double-Stranded RNA in Vesicular Stomatitis Virus-Infected Cells Activates a Constitutive Cell-Type-Specific Antiviral Response. J. Virol. 81: 503-513 [Abstract] [Full Text]  
  • Mibayashi, M., Martinez-Sobrido, L., Loo, Y.-M., Cardenas, W. B., Gale, M. Jr., Garcia-Sastre, A. (2007). Inhibition of Retinoic Acid-Inducible Gene I-Mediated Induction of Beta Interferon by the NS1 Protein of Influenza A Virus. J. Virol. 81: 514-524 [Abstract] [Full Text]  
  • Kopecky-Bromberg, S. A., Martinez-Sobrido, L., Frieman, M., Baric, R. A., Palese, P. (2007). Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists. J. Virol. 81: 548-557 [Abstract] [Full Text]  
  • Shin, Y.-K., Liu, Q., Tikoo, S. K., Babiuk, L. A., Zhou, Y. (2007). Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J. Gen. Virol. 88: 13-18 [Abstract] [Full Text]  
  • Garcia, M. A., Gil, J., Ventoso, I., Guerra, S., Domingo, E., Rivas, C., Esteban, M. (2006). Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action. Microbiol. Mol. Biol. Rev. 70: 1032-1060 [Abstract] [Full Text]  
  • Dauber, B., Schneider, J., Wolff, T. (2006). Double-Stranded RNA Binding of Influenza B Virus Nonstructural NS1 Protein Inhibits Protein Kinase R but Is Not Essential To Antagonize Production of Alpha/Beta Interferon. J. Virol. 80: 11667-11677 [Abstract] [Full Text]  
  • Li, Z., Jiang, Y., Jiao, P., Wang, A., Zhao, F., Tian, G., Wang, X., Yu, K., Bu, Z., Chen, H. (2006). The NS1 Gene Contributes to the Virulence of H5N1 Avian Influenza Viruses. J. Virol. 80: 11115-11123 [Abstract] [Full Text]  
  • Hale, B. G., Jackson, D., Chen, Y.-H., Lamb, R. A., Randall, R. E. (2006). Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc. Natl. Acad. Sci. USA 103: 14194-14199 [Abstract] [Full Text]  
  • Kok, K. H., Jin, D.-Y. (2006). Influenza A virus NS1 protein does not suppress RNA interference in mammalian cells. J. Gen. Virol. 87: 2639-2644 [Abstract] [Full Text]  
  • Fernandez-Sesma, A., Marukian, S., Ebersole, B. J., Kaminski, D., Park, M.-S., Yuen, T., Sealfon, S. C., Garcia-Sastre, A., Moran, T. M. (2006). Influenza Virus Evades Innate and Adaptive Immunity via the NS1 Protein.. J. Virol. 80: 6295-6304 [Abstract] [Full Text]  
  • Cardenas, W. B., Loo, Y.-M., Gale, M. Jr., Hartman, A. L., Kimberlin, C. R., Martinez-Sobrido, L., Saphire, E. O., Basler, C. F. (2006). Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling.. J. Virol. 80: 5168-5178 [Abstract] [Full Text]  
  • Cheng, G., Zhong, J., Chisari, F. V. (2006). Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 103: 8499-8504 [Abstract] [Full Text]  
  • Min, J.-Y., Krug, R. M. (2006). The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. Proc. Natl. Acad. Sci. USA 103: 7100-7105 [Abstract] [Full Text]  
  • Peng, T., Kotla, S., Bumgarner, R. E., Gustin, K. E. (2006). Human rhinovirus attenuates the type I interferon response by disrupting activation of interferon regulatory factor 3.. J. Virol. 80: 5021-5031 [Abstract] [Full Text]  
  • Fredericksen, B. L., Gale, M. Jr. (2006). West Nile Virus Evades Activation of Interferon Regulatory Factor 3 through RIG-I-Dependent and -Independent Pathways without Antagonizing Host Defense Signaling. J. Virol. 80: 2913-2923 [Abstract] [Full Text]  
  • Garaigorta, U., Falcon, A. M., Ortin, J. (2005). Genetic Analysis of Influenza Virus NS1 Gene: a Temperature-Sensitive Mutant Shows Defective Formation of Virus Particles. J. Virol. 79: 15246-15257 [Abstract] [Full Text]  
  • Nishio, M., Tsurudome, M., Ito, M., Ito, Y. (2005). Human Parainfluenza Virus Type 4 Is Incapable of Evading the Interferon-Induced Antiviral Effect. J. Virol. 79: 14756-14768 [Abstract] [Full Text]  
  • Melchjorsen, J., Jensen, S. B., Malmgaard, L., Rasmussen, S. B., Weber, F., Bowie, A. G., Matikainen, S., Paludan, S. R. (2005). Activation of Innate Defense against a Paramyxovirus Is Mediated by RIG-I and TLR7 and TLR8 in a Cell-Type-Specific Manner. J. Virol. 79: 12944-12951 [Abstract] [Full Text]  
  • Falcon, A. M., Fernandez-Sesma, A., Nakaya, Y., Moran, T. M., Ortin, J., Garcia-Sastre, A. (2005). Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins. J. Gen. Virol. 86: 2817-2821 [Abstract] [Full Text]  
  • Unterstab, G., Ludwig, S., Anton, A., Planz, O., Dauber, B., Krappmann, D., Heins, G., Ehrhardt, C., Wolff, T. (2005). Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc. Natl. Acad. Sci. USA 102: 13640-13645 [Abstract] [Full Text]  
  • Lee, D. C. W., Cheung, C.-Y., Law, A. H. Y., Mok, C. K. P., Peiris, M., Lau, A. S. Y. (2005). p38 Mitogen-Activated Protein Kinase-Dependent Hyperinduction of Tumor Necrosis Factor Alpha Expression in Response to Avian Influenza Virus H5N1. J. Virol. 79: 10147-10154 [Abstract] [Full Text]  
  • Osterlund, P., Veckman, V., Siren, J., Klucher, K. M., Hiscott, J., Matikainen, S., Julkunen, I. (2005). Gene Expression and Antiviral Activity of Alpha/Beta Interferons and Interleukin-29 in Virus-Infected Human Myeloid Dendritic Cells. J. Virol. 79: 9608-9617 [Abstract] [Full Text]  
  • Brzozka, K., Finke, S., Conzelmann, K.-K. (2005). Identification of the Rabies Virus Alpha/Beta Interferon Antagonist: Phosphoprotein P Interferes with Phosphorylation of Interferon Regulatory Factor 3. J. Virol. 79: 7673-7681 [Abstract] [Full Text]  
  • La Rocca, S. A., Herbert, R. J., Crooke, H., Drew, T. W., Wileman, T. E., Powell, P. P. (2005). Loss of Interferon Regulatory Factor 3 in Cells Infected with Classical Swine Fever Virus Involves the N-Terminal Protease, Npro. J. Virol. 79: 7239-7247 [Abstract] [Full Text]  
  • Shaw, M. L., Cardenas, W. B., Zamarin, D., Palese, P., Basler, C. F. (2005). Nuclear Localization of the Nipah Virus W Protein Allows for Inhibition of both Virus- and Toll-Like Receptor 3-Triggered Signaling Pathways. J. Virol. 79: 6078-6088 [Abstract] [Full Text]  
  • Spann, K. M., Tran, K. C., Collins, P. L. (2005). Effects of Nonstructural Proteins NS1 and NS2 of Human Respiratory Syncytial Virus on Interferon Regulatory Factor 3, NF-{kappa}B, and Proinflammatory Cytokines. J. Virol. 79: 5353-5362 [Abstract] [Full Text]  
  • Breiman, A., Grandvaux, N., Lin, R., Ottone, C., Akira, S., Yoneyama, M., Fujita, T., Hiscott, J., Meurs, E. F. (2005). Inhibition of RIG-I-Dependent Signaling to the Interferon Pathway during Hepatitis C Virus Expression and Restoration of Signaling by IKK{varepsilon}. J. Virol. 79: 3969-3978 [Abstract] [Full Text]  
  • Barro, M., Patton, J. T. (2005). Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc. Natl. Acad. Sci. USA 102: 4114-4119 [Abstract] [Full Text]  
  • Marcus, P. I., Rojek, J. M., Sekellick, M. J. (2005). Interferon Induction and/or Production and Its Suppression by Influenza A Viruses. J. Virol. 79: 2880-2890 [Abstract] [Full Text]  
  • Stasakova, J., Ferko, B., Kittel, C., Sereinig, S., Romanova, J., Katinger, H., Egorov, A. (2005). Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1{beta} and 18. J. Gen. Virol. 86: 185-195 [Abstract] [Full Text]  
  • Ferko, B., Stasakova, J., Romanova, J., Kittel, C., Sereinig, S., Katinger, H., Egorov, A. (2004). Immunogenicity and Protection Efficacy of Replication-Deficient Influenza A Viruses with Altered NS1 Genes. J. Virol. 78: 13037-13045 [Abstract] [Full Text]  
  • Donelan, N. R., Dauber, B., Wang, X., Basler, C. F., Wolff, T., Garcia-Sastre, A. (2004). The N- and C-Terminal Domains of the NS1 Protein of Influenza B Virus Can Independently Inhibit IRF-3 and Beta Interferon Promoter Activation. J. Virol. 78: 11574-11582 [Abstract] [Full Text]  
  • Abate, D. A., Watanabe, S., Mocarski, E. S. (2004). Major Human Cytomegalovirus Structural Protein pp65 (ppUL83) Prevents Interferon Response Factor 3 Activation in the Interferon Response. J. Virol. 78: 10995-11006 [Abstract] [Full Text]  
  • Billecocq, A., Spiegel, M., Vialat, P., Kohl, A., Weber, F., Bouloy, M., Haller, O. (2004). NSs Protein of Rift Valley Fever Virus Blocks Interferon Production by Inhibiting Host Gene Transcription. J. Virol. 78: 9798-9806 [Abstract] [Full Text]  
  • Kash, J. C., Basler, C. F., Garcia-Sastre, A., Carter, V., Billharz, R., Swayne, D. E., Przygodzki, R. M., Taubenberger, J. K., Katze, M. G., Tumpey, T. M. (2004). Global Host Immune Response: Pathogenesis and Transcriptional Profiling of Type A Influenza Viruses Expressing the Hemagglutinin and Neuraminidase Genes from the 1918 Pandemic Virus. J. Virol. 78: 9499-9511 [Abstract] [Full Text]  
  • Wurzer, W. J., Ehrhardt, C., Pleschka, S., Berberich-Siebelt, F., Wolff, T., Walczak, H., Planz, O., Ludwig, S. (2004). NF-{kappa}B-dependent Induction of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) and Fas/FasL Is Crucial for Efficient Influenza Virus Propagation. J. Biol. Chem. 279: 30931-30937 [Abstract] [Full Text]  
  • Thomas, D., Blakqori, G., Wagner, V., Banholzer, M., Kessler, N., Elliott, R. M., Haller, O., Weber, F. (2004). Inhibition of RNA Polymerase II Phosphorylation by a Viral Interferon Antagonist. J. Biol. Chem. 279: 31471-31477 [Abstract] [Full Text]  
  • Jing, X., Cerveny, M., Yang, K., He, B. (2004). Replication of Herpes Simplex Virus 1 Depends on the {gamma}134.5 Functions That Facilitate Virus Response to Interferon and Egress in the Different Stages of Productive Infection. J. Virol. 78: 7653-7666 [Abstract] [Full Text]  
  • Fredericksen, B. L., Smith, M., Katze, M. G., Shi, P.-Y., Gale, M. Jr. (2004). The Host Response to West Nile Virus Infection Limits Viral Spread through the Activation of the Interferon Regulatory Factor 3 Pathway. J. Virol. 78: 7737-7747 [Abstract] [Full Text]  
  • Falcon, A. M., Marion, R. M., Zurcher, T., Gomez, P., Portela, A., Nieto, A., Ortin, J. (2004). Defective RNA Replication and Late Gene Expression in Temperature-Sensitive Influenza Viruses Expressing Deleted Forms of the NS1 Protein. J. Virol. 78: 3880-3888 [Abstract] [Full Text]  
  • Delhaye, S., van Pesch, V., Michiels, T. (2004). The Leader Protein of Theiler's Virus Interferes with Nucleocytoplasmic Trafficking of Cellular Proteins. J. Virol. 78: 4357-4362 [Abstract] [Full Text]  
  • Bensaude, E., Turner, J. L. E., Wakeley, P. R., Sweetman, D. A., Pardieu, C., Drew, T. W., Wileman, T., Powell, P. P. (2004). Classical swine fever virus induces proinflammatory cytokines and tissue factor expression and inhibits apoptosis and interferon synthesis during the establishment of long-term infection of porcine vascular endothelial cells. J. Gen. Virol. 85: 1029-1037 [Abstract] [Full Text]  
  • Collins, S. E., Noyce, R. S., Mossman, K. L. (2004). Innate Cellular Response to Virus Particle Entry Requires IRF3 but Not Virus Replication. J. Virol. 78: 1706-1717 [Abstract] [Full Text]  
  • Dauber, B., Heins, G., Wolff, T. (2004). The Influenza B Virus Nonstructural NS1 Protein Is Essential for Efficient Viral Growth and Antagonizes Beta Interferon Induction. J. Virol. 78: 1865-1872 [Abstract] [Full Text]  
  • Donelan, N. R., Basler, C. F., Garcia-Sastre, A. (2003). A Recombinant Influenza A Virus Expressing an RNA-Binding-Defective NS1 Protein Induces High Levels of Beta Interferon and Is Attenuated in Mice. J. Virol. 77: 13257-13266 [Abstract] [Full Text]  
  • Tliba, O., Tliba, S., Da Huang, C., Hoffman, R. K., DeLong, P., Panettieri, R. A. Jr., Amrani, Y. (2003). Tumor Necrosis Factor {alpha} Modulates Airway Smooth Muscle Function via the Autocrine Action of Interferon {beta}. J. Biol. Chem. 278: 50615-50623 [Abstract] [Full Text]  
  • Burgui, I., Aragon, T., Ortin, J., Nieto, A. (2003). PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes. J. Gen. Virol. 84: 3263-3274 [Abstract] [Full Text]  
  • Munoz-Jordan, J. L., Sanchez-Burgos, G. G., Laurent-Rolle, M., Garcia-Sastre, A. (2003). Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. USA 100: 14333-14338 [Abstract] [Full Text]  
  • Barnes, B. J., Kellum, M. J., Pinder, K. E., Frisancho, J. A., Pitha, P. M. (2003). Interferon Regulatory Factor 5, a Novel Mediator of Cell Cycle Arrest and Cell Death. Cancer Res. 63: 6424-6431 [Abstract] [Full Text]  
  • Valarcher, J.-F., Furze, J., Wyld, S., Cook, R., Conzelmann, K.-K., Taylor, G. (2003). Role of Alpha/Beta Interferons in the Attenuation and Immunogenicity of Recombinant Bovine Respiratory Syncytial Viruses Lacking NS Proteins. J. Virol. 77: 8426-8439 [Abstract] [Full Text]  
  • Basler, C. F., Mikulasova, A., Martinez-Sobrido, L., Paragas, J., Muhlberger, E., Bray, M., Klenk, H.-D., Palese, P., Garcia-Sastre, A. (2003). The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3. J. Virol. 77: 7945-7956 [Abstract] [Full Text]  
  • Kohl, A., Clayton, R. F., Weber, F., Bridgen, A., Randall, R. E., Elliott, R. M. (2003). Bunyamwera Virus Nonstructural Protein NSs Counteracts Interferon Regulatory Factor 3-Mediated Induction of Early Cell Death. J. Virol. 77: 7999-8008 [Abstract] [Full Text]  
  • Efferson, C. L., Schickli, J., Ko, B. K., Kawano, K., Mouzi, S., Palese, P., Garcia-Sastre, A., Ioannides, C. G. (2003). Activation of Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTLs) by Human Dendritic Cells Infected with an Attenuated Influenza A Virus Expressing a CTL Epitope Derived from the HER-2/neu Proto-Oncogene. J. Virol. 77: 7411-7424 [Abstract] [Full Text]  
  • Hagmaier, K., Jennings, S., Buse, J., Weber, F., Kochs, G. (2003). Novel Gene Product of Thogoto Virus Segment 6 Codes for an Interferon Antagonist. J. Virol. 77: 2747-2752 [Abstract] [Full Text]  
  • Skiadopoulos, M. H., Schmidt, A. C., Riggs, J. M., Surman, S. R., Elkins, W. R., St. Claire, M., Collins, P. L., Murphy, B. R. (2002). Determinants of the Host Range Restriction of Replication of Bovine Parainfluenza Virus Type 3 in Rhesus Monkeys Are Polygenic. J. Virol. 77: 1141-1148 [Abstract] [Full Text]  
  • Park, M.-S., Shaw, M. L., Munoz-Jordan, J., Cros, J. F., Nakaya, T., Bouvier, N., Palese, P., Garcia-Sastre, A., Basler, C. F. (2002). Newcastle Disease Virus (NDV)-Based Assay Demonstrates Interferon-Antagonist Activity for the NDV V Protein and the Nipah Virus V, W, and C Proteins. J. Virol. 77: 1501-1511 [Abstract] [Full Text]  
  • Ludwig, S., Wang, X., Ehrhardt, C., Zheng, H., Donelan, N., Planz, O., Pleschka, S., Garcia-Sastre, A., Heins, G., Wolff, T. (2002). The Influenza A Virus NS1 Protein Inhibits Activation of Jun N-Terminal Kinase and AP-1 Transcription Factors. J. Virol. 76: 11166-11171 [Abstract] [Full Text]  
  • Wang, X., Basler, C. F., Williams, B. R. G., Silverman, R. H., Palese, P., Garcia-Sastre, A. (2002). Functional Replacement of the Carboxy-Terminal Two-Thirds of the Influenza A Virus NS1 Protein with Short Heterologous Dimerization Domains. J. Virol. 76: 12951-12962 [Abstract] [Full Text]  
  • Neumann, G., Whitt, M. A., Kawaoka, Y. (2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol. 83: 2635-2662 [Abstract] [Full Text]  
  • Mahalingam, S., Lidbury, B. A. (2002). Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus. Proc. Natl. Acad. Sci. USA 99: 13819-13824 [Abstract] [Full Text]  
  • Mahalingam, S., Meanger, J., Foster, P. S., Lidbury, B. A. (2002). The viral manipulation of the host cellular and immune environments to enhance propagation and survival: a focus on RNA viruses. J. Leukoc. Biol. 72: 429-439 [Abstract] [Full Text]  
  • Barnes, B. J., Kellum, M. J., Field, A. E., Pitha, P. M. (2002). Multiple Regulatory Domains of IRF-5 Control Activation, Cellular Localization, and Induction of Chemokines That Mediate Recruitment of T Lymphocytes. Mol. Cell. Biol. 22: 5721-5740 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Talon, J.
Right arrow Articles by García-Sastre, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Talon, J.
Right arrow Articles by García-Sastre, A.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»